Sunshine Act Meeting, 51877 [2017-24361]
Download as PDF
<![CDATA[
Federal Register / Vol. 82, No. 215 / Wednesday, November 8, 2017 / Notices
51877
2018
Established
quotas
(g)
Basic class
Methamphetamine ...............................................................................................................................................................................
1,446,754
[846,000 grams of levo-desoxyephedrine for use in a non-controlled, non-prescription product; 564,000 grams for methamphetamine mostly for
conversion to a schedule III product; and 36,754 grams for methamphetamine (for sale)]
Methylphenidate ...................................................................................................................................................................................
Morphine (for conversion) ....................................................................................................................................................................
Morphine (for sale) ..............................................................................................................................................................................
Nabilone ...............................................................................................................................................................................................
Noroxymorphone (for conversion) .......................................................................................................................................................
Noroxymorphone (for sale) ..................................................................................................................................................................
Opium (powder) ...................................................................................................................................................................................
Opium (tincture) ...................................................................................................................................................................................
Oripavine ..............................................................................................................................................................................................
Oxycodone (for conversion) ................................................................................................................................................................
Oxycodone (for sale) ...........................................................................................................................................................................
Oxymorphone (for conversion) ............................................................................................................................................................
Oxymorphone (for sale) .......................................................................................................................................................................
Pentobarbital ........................................................................................................................................................................................
Phenazocine ........................................................................................................................................................................................
Phencyclidine .......................................................................................................................................................................................
Phenmetrazine .....................................................................................................................................................................................
Phenylacetone .....................................................................................................................................................................................
Racemethorphan .................................................................................................................................................................................
Racemorphan ......................................................................................................................................................................................
Remifentanil .........................................................................................................................................................................................
Secobarbital .........................................................................................................................................................................................
Sufentanil .............................................................................................................................................................................................
Tapentadol ...........................................................................................................................................................................................
Thebaine ..............................................................................................................................................................................................
64,600,000
4,089,000
33,958,440
31,000
14,044,540
376,000
84,600
564,000
24,534,000
2,453,400
95,692,000
20,962,000
3,395,280
25,850,000
5
35
25
40
5
5
2,820
161,682
1,880
18,388,280
94,000,000
List I Chemicals
Ephedrine (for conversion) ..................................................................................................................................................................
Ephedrine (for sale) .............................................................................................................................................................................
Phenylpropanolamine (for conversion) ................................................................................................................................................
Phenylpropanolamine (for sale) ...........................................................................................................................................................
Pseudoephedrine (for conversion) ......................................................................................................................................................
Pseudoephedrine (for sale) .................................................................................................................................................................
The Administrator also establishes
aggregate production quotas for all other
schedule I and II controlled substances
included in 21 CFR 1308.11 and
1308.12 at zero. In accordance with 21
CFR 1303.13 and 21 CFR 1315.13, upon
consideration of the relevant factors, the
Administrator may adjust the 2018
aggregate production quotas and
assessment of annual needs as needed.
Dated: November 1, 2017.
Robert W. Patterson,
Acting Administrator.
[FR Doc. 2017–24306 Filed 11–7–17; 8:45 am]
ethrower on DSK3G9T082PROD with NOTICES
BILLING CODE 4410–09–P
VerDate Sep<11>2014
17:26 Nov 07, 2017
Jkt 244001
600 E Street NW., Suite 6002,
Washington, DC 20579. Telephone:
(202) 616–6975.
DEPARTMENT OF JUSTICE
Foreign Claims Settlement
Commission
[F.C.S.C. Meeting and Hearing Notice No.
10–17]
Sunshine Act Meeting
Frm 00077
Fmt 4703
Sfmt 4703
Brian M. Simkin,
Chief Counsel.
[FR Doc. 2017–24361 Filed 11–6–17; 8:45 am]
BILLING CODE 4410–BA–P
The Foreign Claims Settlement
Commission, pursuant to its regulations
(45 CFR part 503.25) and the
Government in the Sunshine Act (5
U.S.C. 552b), hereby gives notice in
regard to the scheduling of open
meetings as follows:
THURSDAY, NOVEMBER 16, 2017: 10:00
a.m.—Issuance of Proposed Decisions in
claims against Iraq.
STATUS: Open.
All meetings are held at the Foreign
Claims Settlement Commission, 600 E
Street NW., Washington, DC. Requests
for information, or advance notices of
intention to observe an open meeting,
may be directed to: Patricia M. Hall,
Foreign Claims Settlement Commission,
PO 00000
47,000
4,136,000
14,100,000
7,990,000
40
180,000,000
DEPARTMENT OF JUSTICE
Notice of Lodging of Proposed
Consent Decree Under the Clean Air
Act
On October 31, 2017, the Department
of Justice lodged a proposed consent
decree with the United States District
Court for the District of Colorado in the
lawsuit entitled United States of
America and the State of Colorado v.
PDC Energy, Inc., Civil Action No. 1:17–
cv–01552–MSK–MJW.
The lawsuit seeks injunctive relief
and civil penalties for violations of the
Clean Air Act, the Colorado Air
E:\FR\FM\08NON1.SGM
08NON1
]]>Agencies
[Federal Register Volume 82, Number 215 (Wednesday, November 8, 2017)]
[Notices]
[Page 51877]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-24361]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Foreign Claims Settlement Commission
[F.C.S.C. Meeting and Hearing Notice No. 10-17]
Sunshine Act Meeting
The Foreign Claims Settlement Commission, pursuant to its
regulations (45 CFR part 503.25) and the Government in the Sunshine Act
(5 U.S.C. 552b), hereby gives notice in regard to the scheduling of
open meetings as follows:
Thursday, November 16, 2017: 10:00 a.m.--Issuance of Proposed Decisions
in claims against Iraq.
Status: Open.
All meetings are held at the Foreign Claims Settlement Commission,
600 E Street NW., Washington, DC. Requests for information, or advance
notices of intention to observe an open meeting, may be directed to:
Patricia M. Hall, Foreign Claims Settlement Commission, 600 E Street
NW., Suite 6002, Washington, DC 20579. Telephone: (202) 616-6975.
Brian M. Simkin,
Chief Counsel.
[FR Doc. 2017-24361 Filed 11-6-17; 8:45 am]
BILLING CODE 4410-BA-P
